Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedXV
XTX Ventures
Activity from announced rounds
Activity in this selectionEurope
- Rounds participated in
- 4
- Confirmed lead rounds
- — 4 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $541.1M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionValarian
Building the sovereign infrastructure layer for high-consequence operations and AI-driven systems
$50MSeries A
Role not disclosedProxima Fusion
Develops commercial fusion power plants based on stellarator concept
€411MGrowth
Role not disclosedQMatter
Develops quantum compression technology to enable computation on existing quantum and classical systems
$1.2MPre-Seed
Role not disclosed